Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IHC 2021 | Update on potential drugs targeting delta and kappa opioid receptors

Amynah Pradhan • 7 Sep 2021
IHC 2021
Headache

Amynah Pradhan, PhD, University of Illinois at Chicago, Chicago, IL, talks on preclinical research that is being done targeting delta and kappa receptors in migraine treatment. Dr Pradhan discusses the clinical trials being carried out by Trevena on delta opioid receptor ligands. Preclinical kappa opioid receptor research is also being carried out with kappa antagonists being developed or in clinical trials for stress disorders which may be useful in migraine treatment. This interview took place during the International Headache Congress 2021.

More from Amynah Pradhan

Research goals from the American Headache Society
2:57
Research goals from the American Headache Society
Amynah Pradhan • 10 Jun 2024
Potential of delta opioid receptors as a target for migraine
2:02
Potential of delta opioid receptors as a target for migraine
Amynah Pradhan • 10 Jun 2024
Developing delta opioid receptor agonists for migraine treatment
2:01
Developing delta opioid receptor agonists for migraine treatment
Amynah Pradhan • 10 Jun 2024
What makes migraine worse?
1:22
What makes migraine worse?
Amynah Pradhan • 20 Jun 2022

Related Videos

TRIPLE study: triple combination therapy for chronic migraine
2:41
TRIPLE study: triple combination therapy for chronic migraine
Marina Romozzi • 27 Jun 2026
PACAP-38 is increased in the tear fluid of patients with migraine
1:50
PACAP-38 is increased in the tear fluid of patients with migraine
Marina Romozzi • 27 Jun 2026
CONFIDENCE: real-world consistency of response to rimegepant for the acute treatment of migraine
5:05
CONFIDENCE: real-world consistency of response to rimegepant for the acute treatment of migraine
Richard Lipton • 1 Jul 2026
RESOLUTION: eptinezumab and patient education for chronic migraine and medication-overuse headache
6:48
RESOLUTION: eptinezumab and patient education for chronic migraine and medication-overuse headache
Richard Lipton • 1 Jul 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals